Patients Paid When Takeda Hid Actos Cancer Risks, Suit Says

The mass of litigation accusing Takeda Pharmaceuticals America Inc. of hiding that its diabetes drug Actos causes bladder cancer continued to grow Tuesday, with a new potential class action in California...

Already a subscriber? Click here to view full article